Resistance to Oral Therapy in Lung Cancer
NCT04546282
·
clinicaltrials.gov ↗
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Non Small Cell Lung Cancer
Interventions
OTHER:
Description of the molecular alterations detected in blood samples of patients treated by osimertinib
Sponsor
University Hospital, Montpellier